13-[(2'R,3'S)-3'-(N-tert-butoxycarbonyl)amino-2'-hydroxy-5'-methylhexanoate]-9(R)-dihydro-baccatin-III | 345983-44-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: 13-[(2'R,3'S)-3'-(N-tert-butoxycarbonyl)amino-2'-hydroxy-5'-methylhexanoate]-9(R)-dihydro-baccatin-III
• 英文别名: [(1S,2S,3R,4S,7R,9S,10S,11R,12R,15S)-4,12-diacetyloxy-1,9,11-trihydroxy-15-[(2R,3S)-2-hydroxy-5-methyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoyl]oxy-10,14,17,17-tetramethyl-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
• CAS: 345983-44-0
• 化学式: C₄₃H₆₁NO₁₅
• 分子量: 831.955
• InChiKey: YCYVRUILLJGBJG-KOJLWRFKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  59
• 可旋转键数：
  16
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  234
• 氢给体数：
  5
• 氢受体数：
  15

反应信息

• 作为反应物：
  描述：

  13-[(2'R,3'S)-3'-(N-tert-butoxycarbonyl)amino-2'-hydroxy-5'-methylhexanoate]-9(R)-dihydro-baccatin-III 在 camphor-10-sulfonic acid 、 三氟乙酸 作用下， 以 二氯甲烷 、 甲苯 为溶剂， 生成
  参考文献：
  名称：

  [EN] TAXANE AND ABEO-TAXANE ANALOGS
  [FR] ANALOGUES DU TAXANE ET DE L'ABÉO-TAXANE

  摘要：

  本申请公开了新的紫杉醇类似物、中间体以及生产它们的方法。本申请还涉及包含阿贝奥紫杉醇的药物配方以及使用阿贝奥紫杉醇治疗癌症的方法。

  公开号：

  WO2013106029A1
• 作为产物：
  描述：

  (3R,4S)-1-(tert-butyloxycarbonyl)-3-triethylsilyloxy-4-(2-methylpropyl)azetidin-2-one 在 盐酸 、 lithium hexamethyldisilazane 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 14.5h， 生成 13-[(2'R,3'S)-3'-(N-tert-butoxycarbonyl)amino-2'-hydroxy-5'-methylhexanoate]-9(R)-dihydro-baccatin-III
  参考文献：
  名称：

  An Efficient Synthesis of the Taxane-Derived Anticancer Agent ABT-271

  摘要：

  ABT-271, 1, has been identified as a promising anticancer agent. ABT-271 is a novel taxane possessing a CS-(R)-hydroxyl group as opposed to a CS-ketone which is present in Taxol and Taxotere. To further evaluate ABT-271 as a potential anticancer agent, an efficient synthesis was developed which allows the large scale synthesis of ABT-271. Ketalization of the 7,9-diol of 9-DHAB-III, 2, allows selective removal of th:e CI-acetate with phenyllithium. The resulting C13-hydroxyl group is then acylated using LiHMDS and beta -lactam 22 to give ABT-271 in protected form. The protecting groups were removed first by acidic hydrolysis followed by basic hydrolysis to provide ABT-271. Application of this synthetic sequence provided over 600 g of ABT-271, 1.

  DOI：

  10.1021/jo0057203

文献信息

• Synthesis and Biological Evaluation of C-3'-Modified Analogs of 9(R)-Dihydrotaxol
  作者：Leping Li、Sheela A. Thomas、Larry L. Klein、Clinton M. Yeung、Clarence J. Maring、David J. Grampovnik、Paul A. Lartey、Jacob J. Plattner

  DOI：10.1021/jm00043a005

  日期：1994.8

  Taxol (1) is considered a most exciting new drug in cancer chemotherapy. The promising antitumor activity of 9(R)-dihydrotaxol (3) encouraged us to further explore the structure-activity relationship of this new member of the taxane family. Studies indicated that the C-13 side chain of taxol is indispensable for antitumor activity and that the natural substitution pattern of a 2'(R)-hydroxy and a 3'(S)-acylamino

  紫杉醇（1）被认为是癌症化疗中最令人兴奋的新药。9（R）-二氢紫杉醇（3）的有希望的抗肿瘤活性鼓励我们进一步探索紫杉烷家族这个新成员的结构-活性关系。研究表明，紫杉醇的C-13侧链对于抗肿瘤活性是必不可少的，并且2'（R）-羟基和3'（S）-酰氨基的天然取代方式可能是最佳的。然而，关于3'-苯环对活性的影响了解的很少。描述了在C-3'位置修饰的3的类似物的合成和生物学评估。这项研究表明3'-苯环不是活性所必需的，并鉴定了几种在体外和体内活性均与紫杉醇相同或更高的化合物。
• An Efficient Synthesis of the Taxane-Derived Anticancer Agent ABT-271
  作者：John A. DeMattei、M. Robert Leanna、Wenke Li、Paul J. Nichols、Michael W. Rasmussen、Howard E. Morton

  DOI：10.1021/jo0057203

  日期：2001.5.1

  ABT-271, 1, has been identified as a promising anticancer agent. ABT-271 is a novel taxane possessing a CS-(R)-hydroxyl group as opposed to a CS-ketone which is present in Taxol and Taxotere. To further evaluate ABT-271 as a potential anticancer agent, an efficient synthesis was developed which allows the large scale synthesis of ABT-271. Ketalization of the 7,9-diol of 9-DHAB-III, 2, allows selective removal of th:e CI-acetate with phenyllithium. The resulting C13-hydroxyl group is then acylated using LiHMDS and beta -lactam 22 to give ABT-271 in protected form. The protecting groups were removed first by acidic hydrolysis followed by basic hydrolysis to provide ABT-271. Application of this synthetic sequence provided over 600 g of ABT-271, 1.
• [EN] TAXANE AND ABEO-TAXANE ANALOGS<br/>[FR] ANALOGUES DU TAXANE ET DE L'ABÉO-TAXANE
  申请人：ARBOR THERAPEUTICS LLC

  公开号：WO2013106029A1

  公开（公告）日：2013-07-18

  The present application discloses new taxane analogs, intermediates and methods for producing them. The present application is also directed to pharmaceutical formulations comprising abeo-taxanes and methods of treating cancer with the abeo-taxanes.

  本申请公开了新的紫杉醇类似物、中间体以及生产它们的方法。本申请还涉及包含阿贝奥紫杉醇的药物配方以及使用阿贝奥紫杉醇治疗癌症的方法。